NOK 18.75
(1.35%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 20.29 Million NOK | 201.69% |
2022 | 16.05 Million USD | -87.5% |
2021 | 128.4 Million NOK | 17.22% |
2020 | 109.53 Million NOK | 16.92% |
2019 | 93.68 Million NOK | 229719.93% |
2018 | 40.76 Thousand USD | 0.0% |
2010 | 33.78 Million NOK | 20.75% |
2009 | 27.98 Million NOK | 190.84% |
2008 | -30.8 Million NOK | 53.98% |
2007 | -66.93 Million NOK | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 5.68 Million NOK | 0.67% |
2024 Q3 | 5.63 Million USD | -0.79% |
2024 Q1 | 5.64 Million USD | 10.02% |
2023 Q3 | 4.58 Million USD | -18.48% |
2023 Q4 | 5.12 Million USD | 11.79% |
2023 FY | 48.43 Million NOK | 201.69% |
2023 Q1 | 4.95 Million USD | -16.65% |
2023 Q2 | 5.62 Million USD | 13.49% |
2022 Q4 | 5.94 Million USD | -84.47% |
2022 Q2 | 37.02 Million NOK | 13.57% |
2022 Q3 | 38.29 Million NOK | 3.43% |
2022 FY | 16.05 Million USD | -87.5% |
2022 Q1 | 32.6 Million NOK | -10.64% |
2021 Q1 | 27.64 Million USD | -3.69% |
2021 Q4 | 36.48 Million NOK | 12.31% |
2021 Q3 | 32.48 Million NOK | 200.48% |
2021 Q2 | -32.33 Million NOK | -216.96% |
2021 FY | 128.4 Million NOK | 17.22% |
2020 Q1 | 30.8 Million USD | 0.0% |
2020 FY | 109.53 Million NOK | 16.92% |
2020 Q4 | 28.7 Million NOK | 11.6% |
2020 Q3 | 25.71 Million NOK | 184.6% |
2020 Q2 | -30.4 Million NOK | -198.69% |
2019 FY | 93.68 Million NOK | 229719.93% |
2018 FY | 40.76 Thousand USD | 0.0% |
2010 FY | 33.78 Million NOK | 20.75% |
2009 FY | 27.98 Million NOK | 190.84% |
2008 FY | -30.8 Million NOK | 53.98% |
2007 FY | -66.93 Million NOK | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Elliptic Laboratories ASA | 28.21 Million NOK | 28.062% |
Zwipe AS | 100.02 Million NOK | 79.707% |